Litcius/Paper detail

ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery

Albert Bou, Morgan Thomas, Sebastian Dittert, Carles Navarro, Maciej Majewski, Ye Wang, Shivam Patel, Gary Tresadern, Mazen Ahmad, Vincent Moens, Woody Sherman, Simone Sciabola, Gianni De Fabritiis

2024Journal of Chemical Information and Modeling23 citationsDOIOpen Access PDF

Abstract

In recent years, reinforcement learning (RL) has emerged as a valuable tool in drug design, offering the potential to propose and optimize molecules with desired properties. However, striking a balance between capabilities, flexibility, reliability, and efficiency remains challenging due to the complexity of advanced RL algorithms and the significant reliance on specialized code. In this work, we introduce ACEGEN, a comprehensive and streamlined toolkit tailored for generative drug design, built using TorchRL, a modern RL library that offers thoroughly tested reusable components. We validate ACEGEN by benchmarking against other published generative modeling algorithms and show comparable or improved performance. We also show examples of ACEGEN applied in multiple drug discovery case studies. ACEGEN is accessible at https://github.com/acellera/acegen-open and available for use under the MIT license.

Topics & Concepts

Reinforcement learningComputer scienceGenerative grammarFlexibility (engineering)BenchmarkingDrug discoveryMachine learningCode (set theory)Artificial intelligenceReliability (semiconductor)LicenseSoftware engineeringSet (abstract data type)Programming languageBioinformaticsPhysicsBiologyPower (physics)Quantum mechanicsMathematicsStatisticsOperating systemMarketingBusinessComputational Drug Discovery MethodsProtein Structure and DynamicsMachine Learning in Materials Science
ACEGEN: Reinforcement Learning of Generative Chemical Agents for Drug Discovery | Litcius